These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 16530441

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using various fresh and stored serum samples.
    Khosravi J, Diamandi A, Bodani U, Khaja N, Krishna RG.
    Clin Biochem; 2005 Jul; 38(7):659-66. PubMed ID: 15885685
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 28. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.
    Justová V, Lacinová Z, Melenovský V, Marek J, Holly JM, Hass T.
    Growth Horm IGF Res; 2001 Dec; 11(6):407-15. PubMed ID: 11914029
    [Abstract] [Full Text] [Related]

  • 29. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 30. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar 01; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 31. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.
    Urology; 2004 Aug 01; 64(2):317-22. PubMed ID: 15302487
    [Abstract] [Full Text] [Related]

  • 32. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 33. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
    Frystyk J, Ivarsen P, Støving RK, Dall R, Bek T, Hagen C, Ørskov H.
    Growth Horm IGF Res; 2001 Apr 15; 11(2):117-27. PubMed ID: 11472078
    [Abstract] [Full Text] [Related]

  • 34. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F.
    Eur Cytokine Netw; 2006 Sep 15; 17(3):167-74. PubMed ID: 17194636
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ, Lukanova A, Rinaldi S, Lundin E, Norat T, Palmqvist R, Stattin P, Riboli E, Hallmans G, Kaaks R.
    Ann Epidemiol; 2006 Jul 15; 16(7):563-71. PubMed ID: 16431135
    [Abstract] [Full Text] [Related]

  • 37. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec 15; 35(12):2363-71. PubMed ID: 19004037
    [Abstract] [Full Text] [Related]

  • 38. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
    Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M.
    Clin Cancer Res; 2003 Aug 15; 9(9):3356-61. PubMed ID: 12960122
    [Abstract] [Full Text] [Related]

  • 39. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 40. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 May 15; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.